Risk of recurrence of subdural hematoma after EMMA vs surgical drainage - Systematic review and meta-analysis
- PMID: 33525919
- PMCID: PMC8392769
- DOI: 10.1177/1591019921990962
Risk of recurrence of subdural hematoma after EMMA vs surgical drainage - Systematic review and meta-analysis
Abstract
Objective: Chronic subdural hematoma (CSDH) is a common and debilitating neurological condition whose treatments, including burr hole drainage and craniotomy, suffer from high rates of recurrence and complication. Embolization of the middle meningeal artery (EMMA) is a promising minimally invasive approach to manage CSDH in a broad set of patients.
Methods: To evaluate the efficacy and safety of EMMA, a database search was conducted including the terms "subdural hematoma; embolization; embolized; middle meningeal" was performed and yielded a total of 260 results. Following exclusion based on predefined criteria, a total of four studies were identified and outcomes including recurrence rates and complication rates were extracted for analysis.
Results: Four studies including intervention and control groups were included with a total of n = 888 patients. The relative risk of CSDH recurrence in the EMMA (3.5%) compared to control group (23.5%) was significantly reduced when EMMA was performed (risk ratio = 0.17; 95% confidence interval (CI) 0.05-0.67). In addition, rates of complication were not significantly different between patients with conventional therapy and those who received EMMA (OR = 0.77; 95 confidence interval (CI) 0.3-1.99).
Conclusion: Based on limited data, EMMA reduces the risk of recurrence by 20% compared to surgical treatment for CSDH.
Keywords: Embolization; chronic subdural hematoma; craniotomy; surgical drainage.
Conflict of interest statement
Figures
References
-
- Yang W, Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am 2017; 28: 205–210. - PubMed
-
- Schwarz F, Loos F, Dünisch P, et al. Risk factors for reoperation after initial burr hole trephination in chronic subdural hematomas. Clin Neurol Neurosurg 2015; 138: 66–71. - PubMed
-
- Oishi M, Toyama M, Tamatani S, et al. Clinical factors of recurrent chronic subdural hematoma. Neurol Med Chir (Tokyo) 2001; 41: 382–386. - PubMed
-
- Kageyama H, Toyooka T, Tsuzuki N, et al. Nonsurgical treatment of chronic subdural hematoma with tranexamic acid. J Neurosurg 2013; 119: 332–337. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
